chrisvoncsefalvay/vaers-outcomes huggingface dataset:
from his nursing home with concerns of weakness, hypotension, and tachycardia, also found to COVID-19 positive. He appears to be asymptomatic from this and has been previously vaccinated so we will simply monitor for the time being. Patient had the moderna vaccine on 10/27
Started vomiting approximately 24 hrs after his second Rotavirus vaccine. Was hospitalized 6/9 6/10. In ED 48.
Information has been received from a published newspaper article concerning an unspecified number of female patients (ages unknown), who on unspecified dates, were vaccinated with doses of GARDASIL. It was reported that the patients experienced short-lived pain and reacted with a "little more than a grimace." Some of the patients also reported that it was "uncomfortable driving with or sleeping on the injected arm for up to a day after getting the shot." At the time of the report, the outcome of the patients were unknown. No further information is avaiable
Pt experience dizziness and fainting upon minutes after receiving H1N1 vaccine. 911 was called. BP of pt. checked adn found to be 116/78, with fast pulse. Pt. talking and smiling but a little disoriented. Taken to ER for observation.
A non-serious, spontaneous report of flu-like-symptoms with symptoms of sore throat has been received from a health professional concerning a teenage male patient subsequent of FLUMIST. Neither medical history nor concomitant medication was provided. The patient received FLUMIST on 02-Dec-2010. Later the same day the patient experienced flu-like symptoms and sore throat. The outcome of the events is unknown.
Information was received on 14-JUN-2017 regarding a case in litigation concerning a male (age not reported). Medical history, concurrent conditions and concomitant medications were not reported. On or about 16-JUL-2015 the patient received a dose of ZOSTAVAX (lot # and dose not specified) as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 05-AUG-2015 the patient was treated at the clinic for a vesicular outbreak that was diagnosed as severe shingles. The patient was prescribed valacyclovir for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
COVID-19, first Immunization - No side affects  COVID-19, Second Immunization - Arm painful, Fever after approximate 4 hours after immunization.  Arm painful for approximately 4 days,  blood sugar ACG  jumping all over 200+ down to 179,\.  Befor Imunication #2 Blood Surgar ACH around 130 -140.  Measure A1C  in December of 2020 8.65
Since I have received the shot, I have had 2 coldsore flare ups on my lips and 2 cases of red eye (I never had pink eye prior to the shots). They seem to occur weekly now since the shot.
19jul90 pt vax hepta B. 1hr later pt presented w/ hives on left hand, itchiness, and tinnitus.  pt tx w/ deltasone and benadryl.
This spontaneous report as received from a medical assistant referring to unspecified number of patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On an unknown date, the patients were vaccinated with improperly stored dose of VAQTA lot # M036459, expiry date: 18-JAN-2018 (dosing details were not reported). It was reported that the vaccines were exposed to a temperature of 0.7C during a time frame of 2 hours. No previous temperature excursion was reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
bilateral hand swelling, flushing of neck and face, feeling hot. Alert and oriented x4, epi-pen to left thigh, Benadryl 50 mg PO, reduced hand swelling, T97.8 F BP 151/91  SpO2  99%  P78. 911 was called, staff assessed pt, did not transport. Pt had friend transport to ER in private vehicle to seek higher level of care as a precaution.
Hives; itching; shortness of breath; chest tightness; severe hip and low back pain; severe hip and low back pain; headache; concomitant medications included mercaptopurine; concomitant medications included mercaptopurine; This is a spontaneous report from a contactable nurse (patient).  A 28-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), intramuscular at right arm on 19Jan2021 at 15:00 at single dose for COVID-19 immunization. The patient medical history included Crohn's disease from an unknown date and unknown if ongoing. The patient's concomitant medications included mercaptopurine, mirtazapine (REMERON), sertraline hydrochloride (ZOLOFT), cetirizine hydrochloride (ZYRTEC). The patient previously took ADDERALL, HUMIRA and REMICADE and experienced allergies. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular at right arm on 30Dec2020 at 15:45 at single dose for COVID-19 immunization. On 20Jan2021 at 06:00, the patient experienced hives, itching, shortness of breath, chest tightness, severe hip and low back pain and headache.  Therapeutic measures were taken as a result of the events and included treatment with diphenhydramine, EPI PEN, TORADOL, acetaminophen, DECADRON, DILAUDID. The patient outcome of the events was resolved with sequel.
2 times i took flu shots, i caught the flu; Initial information received on 31-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who 2 times took flu shots and caught the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event "2 times i took flu shots, i caught the flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (2 times i took flu shots, i caught the flu).  At time of reporting, the outcome was Unknown for the event 2 times i took flu shots, i caught the flu.
Fever, chills, nausea, headache, sever dizziness, vomiting, sever itching of feet, hands, forearms and stomach
On 1/16/04, patient came to the ER with redness and swelling to left arm. Patient received vaccines 2 days ago (DTaP, IPV, MMR). Site slightly painful, low grade temperature. Diagnosed with cellulitis; admitted for 1 day for IV Ancef. Discharged on Keflex 375mg for 7 days. The hospital discharge summary received on 2/25/04 states low grade fever.
Same night of the vaccine I had fevers & chills. They were gone after 12 hrs. On 3/18/2021 I stated having stomach problems. I had diarrhea & cramping this was going on & off. Around one week later I went to urgent care because of how much I was cramping. I followed up with my regular doctor & he did some la work. It kept going on & off but it started getting better & today on 4/12/2021 is the first day I started feeling like myself.
Pfizer BioNTech covid vaccine use for COVID-19 under Emergency Use Authorization (EUA): Developed tetanus after covid vaccine
double vision; blurry vision; metallic tast in mouth; This case was reported by a consumer via call center representative and described the occurrence of taste metallic in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th April 2019, the patient received the 1st dose of Shingrix. On 11th April 2019, immediately after receiving Shingrix, the patient experienced taste metallic. On 13th April 2019, the patient experienced double vision and blurred vision. On 11th April 2019, the outcome of the taste metallic was recovered/resolved. On an unknown date, the outcome of the double vision and blurred vision were recovered/resolved.   It was unknown if the reporter considered the taste metallic, double vision and blurred vision to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix on right arm. The patient reported that almost immediately, she tasted something metallic, which resolved later in the day.   On saturday, 2 days after vaccination the patient began to experience blurred and double vision.   The patient went to an urgent care and was referred to the hospital to rule out stroke.   The patient was not admitted, but had X-rays, CT scan, MRI scan, and blood work which was all normal.   The patient then follow up by her eye physician and was informed that everything looked normal.  The patient reported that the double and blurred vision has improved. The reporter consented to follow up.  The emergency room visit was required. The lot number was not available
A pharmacist reported that a 43 year old female received an injection of Flu Shield. Within 24 hours, she developed an injection site reaction characterized by redness, swelling, warmth and a "knot" the size of a softball." As of 10/18/99, the swelling had begun to subside. This is 1 of 3 pt's from this facility who developed an injection site reaction following receipt of Flu Shield.
Vomiting for 3 days; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting for 3 days) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Vomiting for 3 days) and HEADACHE (Headache). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Vomiting, at an unspecified dose and frequency. At the time of the report, VOMITING (Vomiting for 3 days) and HEADACHE (Headache) outcome was unknown.            No concomitant medication were reported .  Pharmacist gave her Zofran as a treatment medication for vomiting , Patient refused to take Zofran because it messes with her brain.   This case was linked to MOD-2021-221341 (Patient Link).
I was already into day 3 of my period, but I continued bleeding for another month straight. I saw a GYN. I had an ultrasound completed, but I still need to have bloodwork done. The doctor said that everything looks normal from my ultrasound on one side. They couldn't see the other side because I have a small bladder.
pt recv vax 1MAY97 & MAY97 exp inj site soreness that radiated down arm to forearm, as well as constant deep muscle pain over the deltoid muscle;poss also devel a small knot;pt taken to ER 7MAY97;
gout flare ups during the 2 covid vaccines; This is a spontaneous report from a contactable other hcp (patient). A 46-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in left arm on 20Jan2021 10:30 AM (at the age of 46-years-old) as single dose for Covid-19 immunization and received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in left arm on 10Feb2021 10:30 AM (at the age of 46-years-old) as single dose for Covid-19 immunization. The patient's medical history included hypertension from an unknown date and unknown if ongoing and and ongoing gout. The patient's concomitant medications were not reported. On 23Jan2021, the patient got gout flare ups during the 2 covid vaccines and no treatment received. The outcome of the event was not recovered.  Follow-up attempts completed. No further information expected.
Fluzone 0.5ml injection given IM in deltoid of prominant arm at 1600 on 11/13/2008 at the infection control department of hospital(where she works in ER as a Physicians Associate).At 1730 pain in throat(near vocal cords) was noted and 15-20 mins thereafter recurrent dry cough,continued pain from throat inflammation,difficulty breathing,sob,chest tightness and wheezing.Albuterol/Atrovent updraft treatment given and po Claritin and Prednisone also given.At 1830 extreme itching/burning of eyes noted with redness and swelling of eyelids.Purulent yellowish, green discharge from eyes also occured.Benadryl 25mg IM x1 dose given at 2000 while in hospital and then 25mg po x1 dose taken at 2030 at home.By 2130 the breathing,itching & swelling of eyelids was much better with eyes being just a little irritated,slightly red.At 10pm when retiring to bed only a headache was noted.The next day at around 3pm at work extreme nasal congestion and scratchy throat noted which worsened over the next few days until 11/20/2008 when feeling much better.ADR was reported on 11/14/2008 to infection control at hospital.Prior history of recieving yearly flu shot without ill effects until this year.She was advised against recieving flu shot in future due to this ADR-she agreed to this.
Day 3 after the vaccine: I started to experience severe pain on base of skull, lightheadedness, nausea.. Symptoms resembled a migraine, but my prescription migraine medication only helped for a couple of hours. I also had an upset stomach on days 5-12, approximately.
Husband called pharmacy to advise that his wife was severely lethargic and was not able to get up from her bed. Husband was advised to call the fire department due to her condition and age.
within 24 hours of this vaccine, the patient had a stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 101-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Mar2021 as dose 2, single (Lot number: EL9267) at the age of 100 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. There were no known allergies. No covid prior vaccination. Vaccination history included: BNT162b2 (Prev dose lot number: EL9269, Prev dose administration date: 25Feb2021, Prev dose dose number 1, Prev dose vaccine location: Left arm), administration date: 25Feb2021, when the patient was 100-year-old, for Covid-19 Immunization. No other vaccine was taken in four weeks. The following information was reported: CEREBROVASCULAR ACCIDENT (death, disability, medically significant) with onset 19Mar2021, outcome "fatal", described as "within 24 hours of this vaccine, the patient had a stroke". Therapeutic measures were not taken as a result of cerebrovascular accident. No covid tested post vaccination. The patient date of death was 22Mar2021. Reported cause of death: "within 24 hours of this vaccine, the patient had a stroke". It was not reported if an autopsy was performed. The patient was not tested covid post vaccination.; Reported Cause(s) of Death: within 24 hours of this vaccine, the patient had a stroke
nauseous; weirdness in chest goes from left to right; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for Covid-19 Immunization. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "nauseous"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "weirdness in chest goes from left to right".  Additional information: During the call, caller mentions he had a truck driver come in who stated his sister also had weirdness in her chest after the second shot. This sister did not have phlegm after her first shot. Wants to know if the weirdness in his chest has been reported before. Maybe it is just him and this truck driver's sister who are experiencing this. Stated the weirdness in chest goes from left to right. It is just strange.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101325402 same reporter/product/event, different patient
5 Min after vaccine, pt. reported sharp poking sensation in left chest; heart palpitations. History of heart palpitations.
My period is absent.  The first period after dose one was horrible.  I bled more than I have ever bled in my life.  I took pictures of the blood running down my leg half an hour after changing a pad because I was so scared.  I was prepared to experience another heavy cycle after dose 2, but instead my period never came.   I have taken two pregnancy tests.  I am not pregnant.  I have never missed a period except for during my only pregnancy and during breastfeeding.  I have not missed a period since weaning (11 years ago).  It is a terrible feeling not knowing why your period won't come.
Swelling of upper arm, underarm, upper back. Affected area swollen, red, sore, limits use of arm when lifting. Also pt has sore elbow and wrist.
This spontaneous report as received from a nurse refers to her daughter of unknown age. Over a year ago, the patient was vaccinated with the first dose of GARDASIL 9 (lot number not provided) by intramuscular. On 22-JUN-2016, the patient received the second dose of aforementioned vaccine (inappropriate schedule of drug administration). The reporter reported that the patient "missed doses" of GARDASIL 9. No adverse effect reported. Additional information is not expected as the reporter did not wish further contact.
Lymph nodes under left arm pit swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 11May2021 at 08:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 15:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 07:00, the patient experienced lymph nodes under left arm pit swollen. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event lymph nodes under left arm pit swollen was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was mentioned. No treatment medication was mentioned.
Moderna 1st shot was given to 12 years old kid at the health clinic. Patient experience some pain but no fever as off 01/30/2022. Advil 250mg was given to stop the  pain for 1 dose.
The area around the injection has had a red rash around it that I noticed two days after receiving the vaccine. Its about a 3x3 area. There is also a  visible lump that makes it look like I have a really nice shoulder muscle.
Initial information received on 05-Dec-2018 regarding an unsolicited valid non-serious case received from a physician via a Sanofi-employee (accountant). This case involves a patient (age and gender not reported) who was vaccinated with a dose of PENTACEL (lot number and expiry date was not reported) that was diluted with regular saline instead of the diluent provided on an unknown date. The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant medications were not provided. It was a case of actual medication error due to inappropriate reconstitution technique. It was not reported whether the patient has experienced any adverse events or not. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
15 min p/MMR inject in rt arm; wheal w/erythema appeared; 1 1/2" from inject site approx a quarter in size; Ice pack was applied to area; Examined by clincian & supervisor;
Narrative: Patient reported injection site pain following administration of 1st dose of Pfizer Covid vaccine. Resolved without intervention.
(R) St red pain (pain rating 9 on 0-10 scale) injection given 10/16/08 it in office today 10/27/08 c/o severe pain